Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its executive team with the appointment of a chief commercial officer (CCO) and its first managing director (MD).
Francesca Sadler (pictured above) has joined MDC as CCO. Formerly CCO of contract research organization Charnwood Discovery, she brings more than 20 years of experience in commercializing high-quality scientific services to both UK and international communities.
Responsible for MDC’s communications, commercial and business development teams, Dr Sadler will support the business in building on its external reputation and commercial activities, including its investment portfolio.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze